Funds holding APIMEDS PHARMACEUTICALS US INC
ISIN US03771D1028 · United States
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 109.5K $
- Share of capital
- 0.7 % of 15.1M shares on May 26, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 51,620 | 46.5K $ | 0.34 % | as of Jun 30, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 27,334 | 38.5K $ | 0.00 % | 0.18 % | as of May 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 12,034 | 10.8K $ | 0.08 % | as of Jun 30, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 9,729 | 13.7K $ | 0.06 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 100,717 | -22.2 % |
| 2026Q2 | 4 | +1 | 129,408 | +100.7 % |
| 2026Q1 | 3 | 0 | 64,494 | +37.4 % |
| 2025Q4 | 3 | 46,922 |
Institutional managers
4 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | 490.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 40,051 | 71.7K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 10,550 | 18.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,187 | 7.5K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding APIMEDS PHARMACEUTICALS US INC". https://titelia.com/en/stocks/apimeds-pharmaceuticals-us-inc-US03771D1028